The deadline for bursary applications is 19 April. Please see http://www.echeminfo.com/?q=drugdiscovery2013 for more details and application form. We have tried to keep the application process simple.
We will link the case study work closely this year with the anti-malarial kinase drug design activity we initiated with SAM (http://www.scientistsagainstmalaria.net/).
We published a short article last month in Drug Discovery Today on our approach to collaboration and knowledge infrastructure (http://www.sciencedirect.com/science/article/pii/S1359644613000391).
In the Oxford workshop this year we plan to look at additional new kinase targets and to put a process in place to experimentally test most promising predictions.
Please contact me to discuss your interest in this program or related disocvery initiatives:
Barry Hardy, PhD,
Director, Research and Practice
Douglas Connect GmbH, Baermeggenweg 14, 4314 Zeiningen, Switzerland
Em: Barry Hardy -(at)-! douglasconnect.com
Tel: +41 61 851 0170